Ken Wang

Ken Wang has a diverse work experience spanning multiple industries. Ken is currently the Co-Founder and CEO of Neumarker Inc. and has been in this position since October 2022. Ken is also a Board Director at Hearts & Minds Activity Center since April 2022. Prior to these roles, Ken co-founded WMTherapeutics in August 2020 and served as a Co-Founder and Chairman of the Board at Telesair, Inc starting December 2020. Ken also has experience as a Venture Partner at Ferry Venture Capital since March 2011. Ken served as the Chairman of the Board at Hygealeo Inc. from December 2018 to April 2022. Ken has also held positions such as Board Director at Mesa Biotech, Inc. from 2019 to 2020, President at Movella from October 2014 to September 2018, General Manager and SVP of Sales at Telegent Systems from 2004 to 2010, and Director of Business Development at Harmonic Inc from 2004 to 2005.

Ken Wang received their Bachelor of Science (BS) degree from Peking University from 1985 to 1989. Ken then pursued a Doctor of Philosophy (Ph.D.) degree in Chemical Physics from the University of California, Berkeley, where they studied from 1989 to 1995. After that, they attended The Wharton School and obtained a Master of Business Administration (MBA) degree in Finance, General from 1998 to 2000.